160 related articles for article (PubMed ID: 34932720)
1. Use of antifibrotic drugs in familial interstitial pneumonia: analysis of one family.
Estrella DDR; Mancuzo EV; Corrêa RA
J Bras Pneumol; 2021 Dec; 47(6):e20210244. PubMed ID: 34932720
[No Abstract] [Full Text] [Related]
2. Integrating Genomics Into Management of Fibrotic Interstitial Lung Disease.
Adegunsoye A; Vij R; Noth I
Chest; 2019 May; 155(5):1026-1040. PubMed ID: 30660786
[TBL] [Abstract][Full Text] [Related]
3. Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases.
Torrisi SE; Kahn N; Wälscher J; Sarmand N; Polke M; Lars K; Eichinger M; Heussel CP; Palmucci S; Sambataro FM; Sambataro G; Sambataro D; Vancheri C; Kreuter M
BMC Pulm Med; 2019 Nov; 19(1):213. PubMed ID: 31718637
[TBL] [Abstract][Full Text] [Related]
4. Interstitial Pneumonia Secondary to Hermansky-Pudlak Syndrome Type 4 Treated with Different Antifibrotic Agents.
Itano J; Tanimoto Y; Kimura G; Hamada N; Tanaka H; Ninomiya S; Kosaki K; Miyahara N; Maeda Y; Kiura K
Intern Med; 2021 Mar; 60(5):783-788. PubMed ID: 33229802
[TBL] [Abstract][Full Text] [Related]
5. The extended utility of antifibrotic therapy in progressive fibrosing interstitial lung disease.
Sarkar P; Avram C; Chaudhuri N
Expert Rev Respir Med; 2020 Oct; 14(10):1001-1008. PubMed ID: 32567402
[TBL] [Abstract][Full Text] [Related]
6. Preclinical interstitial lung disease in relatives of familial pulmonary fibrosis patients.
Lucas SEM; Raspin K; Mackintosh J; Glaspole I; Reynolds PN; Chia C; Grainge C; Kendall P; Troy L; Schwartz DA; Wood-Baker R; Walsh SLF; Moodley Y; Robertson J; Macansh S; Walters EH; Chambers D; Corte TJ; Dickinson JL
Pulmonology; 2023; 29(3):257-260. PubMed ID: 36216738
[No Abstract] [Full Text] [Related]
7. [Pulmonary fibrosis].
Prasse A; Holle JU; Müller-Quernheim J
Internist (Berl); 2010 Jan; 51(1):6-13. PubMed ID: 19956919
[TBL] [Abstract][Full Text] [Related]
8. Genetic basis of familial interstitial lung disease: misfolding or function of surfactant protein C?
Whitsett JA
Am J Respir Crit Care Med; 2002 May; 165(9):1201-2. PubMed ID: 11991863
[No Abstract] [Full Text] [Related]
9. When it comes to genes--IPF or NSIP, familial or sporadic--they're all the same.
Rosas IO; Kaminski N
Am J Respir Crit Care Med; 2007 Jan; 175(1):5-6. PubMed ID: 17179494
[No Abstract] [Full Text] [Related]
10. Advances in Targeted Therapy for Progressive Fibrosing Interstitial Lung Disease.
Gibson CD; Kugler MC; Deshwal H; Munger JS; Condos R
Lung; 2020 Aug; 198(4):597-608. PubMed ID: 32591895
[TBL] [Abstract][Full Text] [Related]
11. Inherited interstitial lung disease.
Garcia CK; Raghu G
Clin Chest Med; 2004 Sep; 25(3):421-33, v. PubMed ID: 15331184
[TBL] [Abstract][Full Text] [Related]
12. Nonspecific interstitial pneumonia (NSIP), fibrosis pattern. Case report.
Dalpiaz G; Cancellieri A; Nassetti C; Stasi G
Radiol Med; 2003; 105(1-2):107-11. PubMed ID: 12700554
[No Abstract] [Full Text] [Related]
13. Morphological and molecular motifs of fibrosing pulmonary injury patterns.
Jonigk D; Stark H; Braubach P; Neubert L; Shin HO; Izykowski N; Welte T; Janciauskiene S; Warnecke G; Haverich A; Kuehnel M; Laenger F
J Pathol Clin Res; 2019 Oct; 5(4):256-271. PubMed ID: 31433553
[TBL] [Abstract][Full Text] [Related]
14. Adult-onset familial pulmonary fibrosis in Japanese brothers.
Yoshioka Y; Saiki S; Tsutsumi-Ishii Y; Koyama R; Hirashima N; Harada N; Yamasaki S; Suda K; Fukuchi Y
Pathol Int; 2004 Jan; 54(1):41-6. PubMed ID: 14674994
[TBL] [Abstract][Full Text] [Related]
15. Antiinflammatory and antifibrotic effects of the oral direct thrombin inhibitor dabigatran etexilate in a murine model of interstitial lung disease.
Bogatkevich GS; Ludwicka-Bradley A; Nietert PJ; Akter T; van Ryn J; Silver RM
Arthritis Rheum; 2011 May; 63(5):1416-25. PubMed ID: 21312187
[TBL] [Abstract][Full Text] [Related]
16. Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities.
George PM; Spagnolo P; Kreuter M; Altinisik G; Bonifazi M; Martinez FJ; Molyneaux PL; Renzoni EA; Richeldi L; Tomassetti S; Valenzuela C; Vancheri C; Varone F; Cottin V; Costabel U;
Lancet Respir Med; 2020 Sep; 8(9):925-934. PubMed ID: 32890499
[TBL] [Abstract][Full Text] [Related]
17. Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred.
Thomas AQ; Lane K; Phillips J; Prince M; Markin C; Speer M; Schwartz DA; Gaddipati R; Marney A; Johnson J; Roberts R; Haines J; Stahlman M; Loyd JE
Am J Respir Crit Care Med; 2002 May; 165(9):1322-8. PubMed ID: 11991887
[TBL] [Abstract][Full Text] [Related]
18. [A study of interstitial pneumonia associated with collagen vascular disease--comparison with the data of idiopathic pulmonary fibrosis].
Sato A; Chida K
Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Dec; 31 Suppl():54-61. PubMed ID: 8007475
[TBL] [Abstract][Full Text] [Related]
19. [Experimental study on effect of Angelica sinensis in treating pulmonary interstitial fibrosis in rat].
Wang L; Ruan CL; Yang YL; Liu BF; Zhao L
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2013 Sep; 29(5):450-2. PubMed ID: 24386825
[No Abstract] [Full Text] [Related]
20. [Therapy for idiopathic interstitial pneumonias: steroids--and what else?].
Prasse A; Müller-Quernheim J
Internist (Berl); 2006 Dec; 47(12):1258-62. PubMed ID: 17102999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
